Cleared Traditional

K123690 - CAPNOSTREAM20P WITH HIFI C02 MONITORING

K123690 is an FDA 510(k) clearance for CAPNOSTREAM20P WITH HIFI C02 MONITORING, manufactured by Oridion Medical 1987 , Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 610-day FDA review.

K123690 · Oridion Medical 1987 , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
610d
Days
Class 2
Risk

K123690 is an FDA 510(k) clearance for the CAPNOSTREAM20P WITH HIFI C02 MONITORING. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Oridion Medical 1987 , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on August 5, 2014 after a review of 610 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Oridion Medical 1987 , Ltd. devices

FDA 510(k) Submission Details - K123690

510(k) Number K123690 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2012
Decision Date August 05, 2014
Days to Decision 610 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
470d slower than avg
Panel avg: 140d · This submission: 610d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 230
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K123690.
SOFTECH Plus ETCO2 Cannula
K143469 · Teleflexmedical, Inc. · Feb 2015
CO2 monitoring line with and without in-line filter
K143150 · Besmed Health Business Corp · Feb 2015
IntelAir Nasal Airway Support System
K142467 · Abeon Medical Corporation · Nov 2014
SOFTECH PLUS ETC02 CANNULA
K132946 · Teleflexmedical, Inc. · Jun 2014
CO2 MONITORING LINE, CO2 MONITORING LINE WITH FILTER
K133516 · Flexicare · Apr 2014
DUALGUARD
K140473 · Flexicare Medical, Ltd. · Apr 2014